[go: up one dir, main page]

WO1998057625A3 - Composition for controlling oxidation-reduction - Google Patents

Composition for controlling oxidation-reduction Download PDF

Info

Publication number
WO1998057625A3
WO1998057625A3 PCT/DE1998/001616 DE9801616W WO9857625A3 WO 1998057625 A3 WO1998057625 A3 WO 1998057625A3 DE 9801616 W DE9801616 W DE 9801616W WO 9857625 A3 WO9857625 A3 WO 9857625A3
Authority
WO
WIPO (PCT)
Prior art keywords
reduction
composition
controlling oxidation
groups
oxidation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1998/001616
Other languages
German (de)
French (fr)
Other versions
WO1998057625A2 (en
Inventor
Sorin Sarzea
Iulian Ionescu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19880716T priority Critical patent/DE19880716D2/en
Priority to AU84337/98A priority patent/AU8433798A/en
Publication of WO1998057625A2 publication Critical patent/WO1998057625A2/en
Publication of WO1998057625A3 publication Critical patent/WO1998057625A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a composition containing a compound which can release free SH groups, an accompanying substance which can act as a carrier or complexing substance, and a reduction agent. According to the invention, the supply of SH groups can be modulated. The inventive composition is suitable for treating complaints associated with an oxidation-reduction imbalance.
PCT/DE1998/001616 1997-06-13 1998-06-15 Composition for controlling oxidation-reduction Ceased WO1998057625A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19880716T DE19880716D2 (en) 1997-06-13 1998-06-15 Redox control composition
AU84337/98A AU8433798A (en) 1997-06-13 1998-06-15 Composition for controlling oxidation-reduction

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19725178.1 1997-06-13
DE19725178A DE19725178A1 (en) 1997-06-13 1997-06-13 Redox control composition

Publications (2)

Publication Number Publication Date
WO1998057625A2 WO1998057625A2 (en) 1998-12-23
WO1998057625A3 true WO1998057625A3 (en) 1999-05-14

Family

ID=7832474

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1998/001616 Ceased WO1998057625A2 (en) 1997-06-13 1998-06-15 Composition for controlling oxidation-reduction

Country Status (3)

Country Link
AU (1) AU8433798A (en)
DE (2) DE19725178A1 (en)
WO (1) WO1998057625A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US3772439A (en) * 1966-07-26 1973-11-13 S Oeriu Composition and process for the stimulation of growth and development of animals
US3777019A (en) * 1971-02-03 1973-12-04 American Home Prod Stabilized chlorpromazine hydrochlo-ride solution for use in disposable cartridges
US4039682A (en) * 1976-03-29 1977-08-02 Baxter Travenol Laboratories, Inc. Method and composition for relief of back pain
WO1994022438A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US3772439A (en) * 1966-07-26 1973-11-13 S Oeriu Composition and process for the stimulation of growth and development of animals
US3777019A (en) * 1971-02-03 1973-12-04 American Home Prod Stabilized chlorpromazine hydrochlo-ride solution for use in disposable cartridges
US4039682A (en) * 1976-03-29 1977-08-02 Baxter Travenol Laboratories, Inc. Method and composition for relief of back pain
WO1994022438A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation

Also Published As

Publication number Publication date
AU8433798A (en) 1999-01-04
WO1998057625A2 (en) 1998-12-23
DE19725178A1 (en) 1998-12-17
DE19880716D2 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
AU3818100A (en) Silane-based coating with a deodorizing effect for domestic appliances
AU4892893A (en) Oral antifungal preventative, and method of use
ZA200001623B (en) Process for the preparation of substantially amorphous alpha-olefin polymers and compositions containing them and process for the preparation of bridged ligand.
PL349447A1 (en) Aqueous reactive putties (ii)
AU2963400A (en) Improved controlled release compositions and method
WO2002022084A3 (en) Concentrated hair conditioning composition
IL140437A0 (en) Pharmaceutical compositions comprising 2-quinolines
AU2726695A (en) Lubricating compositions, concentrates, and greases containing the combination of an organic polysulfide and an overbased composition or a phosphorous or boron compound
AU9446498A (en) Reducing agent with several constituents comprising at least a composition in powder form containing an agent for reducing hair sulphur bonds and method for permanent setting of keratin fibres
AU4763000A (en) Silica sol, composition containing the same, method for treating said silica soland uses thereof
TW337982B (en) Compositions and methods for controlling harmful fungi
GR3030315T3 (en) Tcmtb on a solid carrier in powdered form, method of manufacture and method of use.
EP0366869A3 (en) Bacteriostatic, bactericidal and antifungal composition and methods of use thereof
TW349094B (en) Compositions and methods for controlling harmful fungi
AU7319091A (en) Alternative enzyme substrates as deodorants
WO1999027892A3 (en) Storage-stable cationically polymerised preparations with improved hardening characteristics
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
AU5116590A (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
PL336755A1 (en) Binding agent
WO1998057625A3 (en) Composition for controlling oxidation-reduction
WO1997024925A3 (en) Bactericidal compositions and articles containing them
ZA9710797B (en) High coating weight iron phosphating, compositions therefor, and use of the coating formed as a lubricant carrier.
WO2000038617A3 (en) Compositions and methods of using the same
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
AU4621500A (en) Novel aluminosiloxane compound and process for preparing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: CA

NENP Non-entry into the national phase

Ref document number: 1999503559

Country of ref document: JP

REF Corresponds to

Ref document number: 19880716

Country of ref document: DE

Date of ref document: 20000727

WWE Wipo information: entry into national phase

Ref document number: 19880716

Country of ref document: DE

122 Ep: pct application non-entry in european phase